For hair, patients using GHK-Cu scalp formulations report reduced shedding and improvements in hair thickness and follicle density at 8 to 12 weeks, with maximum improvement at 3 to 6 months of consistent use
Activation of both GIP and GLP-1 receptors by retatrutide probably contributed to the observed changes in circulating triglycerides, as treatment with the dual GIP/GLP-1 receptor agonist tirzepatide significantly reduced triglyceride levels by up to 29% at 52 weeks in a clinical trial in people with T2D and MASLD 8
Referncias e Leitura Complementar: Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., & IDF Diabetes Atlas Committee
Place Your Pharmacy Order Select your medicine (Ozempic, Wegovy, Rybelsus, Mounjaro, or liraglutide)